BRCA1 and breast cancer: Data from several studies indicate that RRSO is associated with a decrease in OC (96%) and BC (50%) occurrence [6] and a significant reduction in the all-cause mortality rate, especially in BRCA1 mutation carriers (HR 0.45, p < 0.0001) [7].